Pennsylvania is currently home to 3463 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Philadelphia, Pittsburgh, Hershey and Allentown. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia
Recruiting
The purpose of this study is to test the efficacy virtual reality videos to facilitate exposure therapy in social anxiety disorder (SAD). The exposure therapy videos are the focus of this experiment. Essentially, we are testing the efficacy of the Virtual Reality Exposure Therapy (VRET) scripts (i.e., virtual scenarios, people, and interactions that we expose socially anxious people to). To this end, the goal of the current study is to help people with social anxiety overcome their phobias. Indi... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2022
Locations: The Pennsylvania State University, University Park, Pennsylvania
Conditions: Social Anxiety Disorder
BMI-Associated Labor Induction: A Prospective Trial
Recruiting
The primary objective of this study is to determine if planned induction of labor at 39 weeks for nulliparous with pre-pregnancy BMI ≥ 35 kg/m2 reduces the incidence of cesarean section compared to expectant management
Gender:
Female
Ages:
18 years and above
Trial Updated:
04/11/2022
Locations: Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
Conditions: Labor Induction
The Impact of Glomerular Disorders on Bone Quality and Strength
Recruiting
The primary objectives of this study are to: (1) determine the impact of glomerular disease on bone strength and (2) investigate the pathophysiologic underpinnings of impaired bone strength in glomerular disease.
Gender:
All
Ages:
Between 5 years and 55 years
Trial Updated:
04/08/2022
Locations: The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Conditions: Glomerular Disease, Bone Diseases, Metabolic, Bone Fracture
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Recruiting
The goal of this study is to investigate that a common cholesterol lowering agent (atorvastatin) alone or combining with a nonsteroidal anti-inflammatory drug (aspirin) would reduce the risk of colorectal cancer (CRC) in high-risk individuals with Lynch syndrome.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
04/06/2022
Locations: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Conditions: Lynch Syndrome
COVID-19 Vaccines Safety Tracking (CoVaST)
Recruiting
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary obje... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2022
Locations: American College of Physicians, Philadelphia, Pennsylvania
Conditions: Adverse Reaction to Vaccine, COVID19 Vaccine
Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)
Recruiting
This is a comparative effectiveness study of two pragmatic models aiming to introduce palliative care for end stage liver disease patients. The 2 comparators are: Model 1: Consultative Palliative Care (i.e. direct access to Palliative Care provider), Model 2: Trained Hepatologist- led PC intervention (i.e. a hepatologist will receive formal training to deliver Palliative Care services) Primary Outcome: The change in quality of life from baseline to 3 months post enrollment as assessed by FACT-... Read More
Gender:
All
Ages:
Between 18 years and 120 years
Trial Updated:
04/05/2022
Locations: Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania
Conditions: End Stage Liver Disease
Helping Hypertension Patients to Interpret Blood Pressure Readings and Motivate Blood Pressure Control
Recruiting
Hypertension is a major risk factor for cardiovascular disease, and a leading cause of death worldwide. Only about 50% of hypertension patients have good blood pressure control. Patients with low health literacy have worse blood pressure control, perhaps because they find it harder to interpret whether blood pressure readings are high or low, reflect good or bad blood pressure control, and indicate a need for behavior change or medication use. The American Heart Association has called for broad... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/28/2022
Locations: Pitt+Me Patient Registry, Pittsburgh, Pennsylvania
Conditions: Hypertension
Hand Forceps vs. Conventional One-hand Technique for Fetal Head Extraction During Cesarean Section
Recruiting
The aim of the study is to assess the efficacy and safety of an innovative two-hand (hand forceps) fetal head extraction technique during the transverse cesarean sections (LTCS) by comparing with the conventional one-hand technique used worldwide for centuries. The primary research question of the study is whether two-hand fetal head extraction technique results in quicker head delivery. The secondary research question is whether two-hand technique would cause increased incidence of extension o... Read More
Gender:
Female
Ages:
All
Trial Updated:
03/28/2022
Locations: Reading Hospital Labor & Delivery, West Reading, Pennsylvania
Conditions: Pregnancy Related, Delivery Complication, Cesarean Delivery Affecting Fetus
The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
Recruiting
The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).
Gender:
All
Ages:
18 years and above
Trial Updated:
03/23/2022
Locations: Scranton Medical Institutes, Moosic, Pennsylvania
Conditions: Treatment Resistant Depression
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
Recruiting
The major objective is to demonstrate the safety and efficacy of ANG-3070 in patients with primary glomerular disease and persistent proteinuria.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/22/2022
Locations: University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Glomerular Disease, Proteinuria
ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program
Recruiting
The investigators have previously shown that youth with MS are very inactive, and that vigorous physical activity is associated with higher levels of well-being and lower MS disease activity in youth. Yet, no effective physical activity interventions have been developed for youth with MS to date. The investigators have taken input from youth with MS to create a Smartphone-based app (the ATOMIC - Active Teens with Multiple Sclerosis - App) that provides tailored physical activity information and... Read More
Gender:
All
Ages:
Between 11 years and 21 years
Trial Updated:
03/15/2022
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Conditions: Pediatric Multiple Sclerosis
Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes
Recruiting
Randomized prospective study to evaluate next generation sequencing (NGS) and standard-of-care culture for clinically infected penile implants and to compare outcomes with identification of microbes.
Gender:
Male
Ages:
Between 18 years and 80 years
Trial Updated:
03/10/2022
Locations: Thomas Jefferson University, Philadelphia, Pennsylvania
Conditions: Penile Implantation, Infections